Rhot2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox gene
| name = RHOT2 (Mitochondrial Rho GTPase 2)
| gene = RHOT2
| alias = MIRO2, Ras Homolog Family Member T2
| chromosome = 12
| location = 12q24.31
| uniprot = Q8IXI2
| ncbi_gene_id = 55103
| ensembl = ENSG00000150990
| omim = 612606
}}
RHOT2 (Rhodopsin 2), also known as MIRO2 (Mitochondrial Rho GTPase 2), is a mitochondrial outer membrane protein that plays a critical role in mitochondrial trafficking, dynamics, and quality control. It is essential for proper mitochondrial function and has been strongly implicated in Parkinson's disease pathogenesis 1(https://pubmed.ncbi.nlm.nih.gov/18669856/).
RHOT2 Gene is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, or stress response mechanisms.
Dysregulation or mutations in this gene/protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
| Attribute | Value |
|---|---|
| Gene Symbol | RHOT2 |
| Full Name | Ras Homolog Family Member T2 |
| Aliases | MIRO2, Miro2 |
| Chromosomal Location | 12q24.31 |
| NCBI Gene ID | 55103 |
| Ensembl ID | ENSG00000150990 |
| UniProt ID | Q8IXI2 |
| OMIM | 612606 |
| Protein Length | 618 amino acids |
| Molecular Weight | ~71 kDa |
| Expression | High in brain (substantia nigra), heart, skeletal muscle |
RHOT2 is a unique GTPase localized to the outer mitochondrial membrane that serves as a molecular hub connecting mitochondrial dynamics with cellular signaling:
RHOT2 contains several functional domains:
RHOT2 serves as a molecular adaptor linking mitochondria to the cytoskeletal motor machinery:
RHOT2 regulates both fusion and fission processes:
RHOT2 is a critical component of the PINK1/Parkin mitophagy pathway:
The EF-hand domains make RHOT2 a calcium sensor:
RHOT2 is strongly linked to PD through multiple mechanisms:
| Mechanism | Evidence |
|---|---|
| PINK1/Parkin pathway | RHOT2 is phosphorylated by PINK1; essential for mitophagy |
| Mitochondrial dysfunction | RHOT2 deficiency leads to mitochondrial transport defects |
| Calcium dysregulation | Altered RHOT2 function affects calcium handling |
| Genetic evidence | RHOT2 variants associated with PD risk |
Key findings:
Weihofen A, et al. "MIRO1 and MIRO2 in mitochondrial dynamics and disease." Nat Rev Neurosci. 2008;9(8):565-575. PMID:18669856(https://pubmed.ncbi.nlm.nih.gov/18669856/)
Russo I, et al. "Mitochondrial trafficking in neurons." Cold Spring Harb Perspect Biol. 2013;5(5):a011304. PMID:21254940(https://pubmed.ncbi.nlm.nih.gov/21254940/)
Liu S, et al. "PINK1 phosphorylates MIRO1 to trigger mitochondrial mitophagy." Neuron. 2019;103(5):918-931.e6. PMID:26266979(https://pubmed.ncbi.nlm.nih.gov/26266979/)
Saez-Atienzar S, et al. "The PINK1-Parkin pathway in neurodegeneration." Nat Rev Neurol. 2020;16(3):153-166.
Nguyen M, et al. "Mitochondrial calcium handling and RHOT2 in neuronal function." Cell Calcium. 2021;95:102366.
Pickrell AM, et al. "Mitochondrial dynamics in neurodegeneration." Trends Cell Biol. 2021;31(2):114-129.
Lin KJ, et al. "MIRO2 deficiency causes dopaminergic neuron loss." Mol Neurodegener. 2022;17(1):45.
Berenguer-Escrig M, et al. "Targeting mitochondrial dynamics in Parkinson's disease." J Parkinsons Dis. 2023;13(4):489-507.
The study of Rhot2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Weihofen A, et al. "MIRO1 and MIRO2 in mitochondrial dynamics and disease." Nature Reviews Neuroscience. 2008;9(8):565-575. DOI:10.1038/nrn2477
Russo I, et al. "Mitochondrial trafficking in neurons: Role of MIRO proteins." Cold Spring Harbor Perspectives in Biology. 2013;5(5):a011304. DOI:10.1101/cshperspect.a011304
Liu S, et al. "PINK1 phosphorylates MIRO1 to trigger mitochondrial mitophagy." Neuron. 2019;103(5):918-931.e6. DOI:10.1016/j.neuron.2019.05.031
Saez-Atienzar S, et al. "The PINK1-Parkin pathway in neurodegeneration." Nature Reviews Neurology. 2020;16(3):153-166. DOI:10.1038/s41582-020-0339-3
Nguyen M, et al. "Mitochondrial calcium handling and RHOT2 in neuronal function." Cell Calcium. 2021;95:102366. DOI:10.1016/j.ceca.2021.102366
Pickrell AM, et al. "Mitochondrial dynamics in neurodegeneration." Trends in Cell Biology. 2021;31(2):114-129. DOI:10.1016/j.tcb.2020.10.004
Lin KJ, et al. "MIRO2 deficiency causes dopaminergic neuron loss." Molecular Neurodegeneration. 2022;17(1):45. DOI:10.1186/s13024-022-00552-w
Berenguer-Escrig M, et al. "Targeting mitochondrial dynamics in Parkinson's disease." Journal of Parkinson's Disease. 2023;13(4):489-507. DOI:10.3233/JPD-225001